{"text": "24                                                                                                                                                                                             Daily Nationffhursday              April 1, 2004\r\nLocal companies start producing Aids drugs\r\n                                                                                                                                                                      Others believe multinational companies fear losing out their market\r\nCONTINUED    FROM PAGE 23                                                                                                                                          share when the drugs are produced locally, and are therefore using\r\n                                                                                                                                                                   their officials to influence decisions at the Ministry of Trade and\r\nmedicines for diseases such as malaria and tuberculosis-the only con-\r\n                                                                                                                                                                   Industry.\r\ndition being that such a disease is considered a national disaster.\r\n                                                                                                                                                                     This is because if the generics are produced locally and sold at\r\n   Kenya qualifies in all these fronts and consequently notified the\r\n                                                                                                                                                                   lower prices, they are likely to push the multinational companies into\r\nWTO of its intentions - to issue compulsory licensing and and/or                                                                                                   revising the prices of their branded ARVs downwards.\r\ngovernment order, licensing local companies to overlook certain pat-                                                                                                 Those who hold this position say their argument is based on the fact\r\nents and manufacture generic ARVs.                                                                                                                                 that the two first line drugs that are under patent, Lamivudine and\r\n   Two of the three drugs - Lamivudine and Efavirenz- recom-                                                                                                       Efavirenz, are products of GlaxoSmithkline and Bristol Myers-Squibb\r\nmended by the Ministry of Health as first line HIV treatment, are                                                                                                  respectively. Both companies have a strong presence locally.           ---oIIIIIIIiiiI\r\nunder patent.                                                                                                                                                         Indeed, speaking at the International Investment Confere~\r\n   Only for the third, Stavudine, has the patent expired and it can be                                                                                             week, Trade and Industry minister Dr Mukhisa Kituyi revealed that a\r\nproduced by any company without a compulsory licence. But                                                                                                          local company wants a compulsory licence to manufacture one of the\r\nbecause the drugs have to be taken as a triple therapy cocktail, it is                                                                                             products owned by GlaxoSmithkline.\r\ninstructive that companies also have a licence to produce the pat-                                                                                                    He admitted that the government was in a dilemma over the matter.\r\nented Lamivudine and Efavirenz.                                                                                                                                    The reason for this, as analysts see it; is that the affected multinational\r\n   In the last few months, there have been press reports that Cosmos                                                                                               companies are operating in the country with local companies, and the\r\nLtd. has been denied a compulsory licence by the Ministry of Trade                                                                                                 government is finding it difficult to come up with a win-win situation.\r\nand Industry to manufacture generic ARVs of some of these first line                                                                                                  When contacted over the issue, a source at GlaxoSmithkline said\r\ndrugs. Yet, the MoH has already given the company a clean bill of                                                                                                  the company was not worried about any local firm being granted a\r\nhealth.                                                                                                                                                            licence to manufacture a generic version of its branded Lamivudine\r\n   It is understood that a plea by Cosmos to the Ministry of Trade and                                                                                             drug.\r\nIndustry to be allowed to produce the drugs is yet to be considered.                                                                                                  Says the source: \"We are highly subsidizing these drugs particularly\r\nBut in an interesting twist of events, a source at the Industrial Prop-                  Dr Mukhisa Kituyi                                                         for Africa. We don't make any profits here but only manage to break\r\nerty Tribunal, the body that considers applications for such licence on                                                                                            even from sales in the developed countries.\"\r\nbehalf of the ministry, says no company has applied for compulsory                      under patent.                                                                 To the source, any company producing a generic of GSK branded\r\nlicensing.                                                                                 Likewise, it is instructive to note that most of the potent ARVs        products will be considered a partner. But he adds a rider: \"However;\r\n   \"Some companies have been misleading the public through the                          drugs, especially the ones for emerging HIV-resistant strains, are still   matters of patent have to be looked into as something small has to\r\nmedia that they have been denied compulsory licensing when they                         under patent, making compulsory licensing or Government Order the          accrue to us.\"\r\nhave not even applied for one,\" says the source.                                        only options for making them.                                                 What is happening in Kenya is said to have been rife in countries\r\n   The source said Cosmos has only applied for a Government Order                          In essence, what this this means is that all products so far regis-     like India and Brazil where the governments overlooked the WTO\r\nto produce generic ARVs, mainly because it had won a government                         tered and approved by the MoH for use in both public and private           patent rules and opposition from multinational pharmaceutical com-\r\ntender.                                                                                 sector, but which are patented, cannot be manufactured for wider           panies to allow their local companies to manufacture generic ARVs\r\n   In its application, Cosmos is said to have also expressed interest to                distribution unless the Ministry of Trade and Industry grants the          was strong.\r\nproduce for the private sector. This would have enabled the firm to                     compulsory licence or Government Order.                                       The issue has remained very sensitive, with some developed coun-\r\nproduce for the East African countries that would order for the drugs                      In fact, sources at MoH say even the government itself, through the     tries threatening to impose trade sanctions on the countries involved.\r\nin line with the WTO's rules of parallel importation.                                   ministry, cannot tender for some drugs it has approved because such           Multinational pharmaceutical companies in the past have moved to\r\n   The tribunal refused to grant that request, seeing another motive in                 a licence has not been issued so far to local companies.                   courts, in South Africa for instance, in an attempt to stop companies\r\nthe move. Says a source at the tribunal: \"Their objective was only to                      Some stakeholders in the industry see an interplay of several fac-      in developing countries from reproducing their products without pay-\r\nsupply the government and not to produce the drugs for competitive                      tors as the reason behind the government's slow pace in issuing the        ing for it.\r\npurposes. This set off alarm bells and we instead asked them to apply                   licences.                                                                     Their argument is that such moves will discourage Research and\r\nfor compulsory licensing.\"                                                                  There is talk that some foreign countries, which are home to major     Development (R&D) as most them are unable to recoup their invest-\r\n   Universal Ltd and Lab and Allied will also have to seek this per-                    multinational pharmaceutical companies, are lobbying the govern-           ments.\r\nmission if they want to produce the first line HIV drugs that are still                 ment not to grant such licence, at least not for now.                      - An A We-Feature\r\n                                                                                               with                    C~/':\r\n                                                                                                                           .\r\n                                _                                                                          ,&L.\r\n                                              A      \". 'it\u00b7\r\n                                                          .\u00b7\u00b7   . \u00b7\u00b7nt' ..... , '. \u00b7 ,\r\n                                                                                   ~ ~CAAIlNORE-\u00b7> . ....\u2022..11\u00b7\u00b7\",' j\r\n                                                                                                           ~St\u00b7 .....\u2022..\u2022. 1                  m,.'J'\r\n                                                                                                                  '.'..\r\n                                                                                                           \u00b7 .;,>;,\u00b7,ti\";<                                                                               .\r\n                                              .............           \u00b7      ..... i.    \",\",eM          > ( ..             0011\r\n   On fri~ayt~e2n~of ApriI2~~4from 191tildawn\r\n   Come and join the biggest Coast Night party                                                                                 \u2022 Sample excifin8!~~(Jstal dish\r\n   Featuring the best Coastal music                                                                                              while danci         exotic,\r\n                                                                                                                                    Nzele,&,                                        band\r\n                                                                                                                                 from t_                                                                                                     \u2022\u2022\u2022\u2022\r\n  BRASSO BAND                                                                                                                                                                                                                                ~\r\n                                                                                                                               \u2022 Free we                                                                                              I     \\\r\n  BANGO SOUNDS (Mzee Ngala Mwenyewe}                                                                                           \u2022 Mnazi in theibolf:s!                                                                                 ,')\r\n  TALENTED TMRAB MELODIES                                                                                                                                                                                                             ~... ...\u2022....\r\n                                                                                                                                                                                                                                      t'.l\r\n   UYOGA\r\n   Dress code: Coast casual\r\n   Entrance: Kshs. 300\r\nPage \f\r\n\r\n\r\n-------------------Trial Version-----------------------\r\n\r\nConvert PDF to Text Desktop Software.\r\n\r\nCopyright Convertpdftotext.net 2014.\r\n\r\nTo remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm\r\n\r\n-------------------------------------------------------"}